Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Jul;37(1):136–139. doi: 10.1136/gut.37.1.136

Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.

M Trauner 1, E Grasmug 1, R E Stauber 1, H F Hammer 1, G Hoefler 1, E C Reisinger 1
PMCID: PMC1382785  PMID: 7672664

Abstract

A 33 year old woman with recurrent Salmonella enteritidis sepsis is described. Penicillins, ceftriaxone, ciprofloxacin, and chloramphenicol could not eradicate the salmonellas but a combination of high dose ciprofloxacin and ceftriaxone for the eighth episode successfully cured the infection. The combination of ciprofloxacin and ceftriaxone may be a valuable therapeutic regimen in patients with recurrent salmonella sepsis. Prolonged intrahepatic cholestasis resulting from granulomatous hepatitis in this patient improved considerably with empiric ursodeoxycholic acid treatment. A liver biopsy specimen showing non-caseating epitheloid granulomas was positive for mycobacterial DNA by polymerase chain reaction. Repeated bronchoscopy with multiple biopsies eventually revealed caseating granulomas with acid fast bacilli in the lung biopsy specimens. Therefore, tuberculosis was diagnosed as the underlying disease and the cause of granulomatous hepatitis in this patient and tuberculostatic treatment was started. Polymerase chain reaction for mycobacterial DNA may be helpful in the differential diagnosis of hepatic granulomas when routine histological examination and culture of biopsy specimens are not diagnostic. Tuberculosis should be considered as one of the diseases predisposing to recurrent salmonella sepsis.

Full text

PDF
136

Images in this article

136Figure 1
on p.136
138Figure 3
on p.138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson S., Kramer S. B., Radin A., Holzman R. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum. 1985 Jan;28(1):75–79. doi: 10.1002/art.1780280112. [DOI] [PubMed] [Google Scholar]
  2. Asperilla M. O., Smego R. A., Jr, Scott L. K. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis. 1990 Sep-Oct;12(5):873–889. doi: 10.1093/clinids/12.5.873. [DOI] [PubMed] [Google Scholar]
  3. Bassa A., Parras F., Reina J., Villar E., Gil J., Alomar P. Non-typhi Salmonella bacteraemia. Infection. 1989 Sep-Oct;17(5):290–293. doi: 10.1007/BF01650710. [DOI] [PubMed] [Google Scholar]
  4. Cherubin C. E., Neu H. C., Imperato P. J., Harvey R. P., Bellen N. Septicemia with non-typhoid salmonella. Medicine (Baltimore) 1974 Sep;53(5):365–376. doi: 10.1097/00005792-197409000-00003. [DOI] [PubMed] [Google Scholar]
  5. Cohen J. I., Bartlett J. A., Corey G. R. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987 Sep;66(5):349–388. doi: 10.1097/00005792-198709000-00003. [DOI] [PubMed] [Google Scholar]
  6. Cunnigham D., Mills P. R., Quigley E. M., Patrick R. S., Watkinson G., MacKenzie J. F., Russell R. I. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med. 1982 Spring;51(202):162–170. [PubMed] [Google Scholar]
  7. ERLIK D., REITLER R. Intrahepatic typhoid infection as cause of the carrier state. Lancet. 1960 Jun 4;1(7136):1216–1218. doi: 10.1016/s0140-6736(60)91098-9. [DOI] [PubMed] [Google Scholar]
  8. Easmon C. S., Crane J. P., Blowers A. Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):43–48. doi: 10.1093/jac/18.supplement_d.43. [DOI] [PubMed] [Google Scholar]
  9. Essop A. R., Posen J. A., Hodkinson J. H., Segal I. Tuberculosis hepatitis: a clinical review of 96 cases. Q J Med. 1984 Autumn;53(212):465–477. [PubMed] [Google Scholar]
  10. Glaser J. B., Morton-Kute L., Berger S. R., Weber J., Siegal F. P., Lopez C., Robbins W., Landesman S. H. Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Feb;102(2):189–193. doi: 10.7326/0003-4819-102-2-189. [DOI] [PubMed] [Google Scholar]
  11. Harrington P. T., Gutiérrez J. J., Ramirez-Ronda C. H., Quiñones-Soto R., Bermúdez R. H., Chaffey J. Granulomatous hepatitis. Rev Infect Dis. 1982 May-Jun;4(3):638–655. doi: 10.1093/clinids/4.3.638. [DOI] [PubMed] [Google Scholar]
  12. Hoppe J. E., Dopfer R., Huber S., Niethammer D. Eradication of Salmonella dublin in an immunodeficient child by combined use of ceftriaxone and ciprofloxacin after failure of either agent alone. Infection. 1989 Nov-Dec;17(6):399–400. doi: 10.1007/BF01645558. [DOI] [PubMed] [Google Scholar]
  13. Leport C., Imbert J. C., Degott C. Confrontation anatomo-clinique. Hôpital de la Pitié-Salpétrière. Hépatite granulomateuse au cours d'une septicémie à Salmonella typhi. Ann Med Interne (Paris) 1984;135(2):158–166. [PubMed] [Google Scholar]
  14. Musher D. M., Rubenstein A. D. Permanent carriers of nontyphosa salmonellae. Arch Intern Med. 1973 Dec;132(6):869–872. [PubMed] [Google Scholar]
  15. Nakoneczna I., Hsu H. S. Histopathological study of protective immunity against murine salmonellosis induced by killed vaccine. Infect Immun. 1983 Jan;39(1):423–430. doi: 10.1128/iai.39.1.423-430.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Plaisance K. I., Drusano G. L., Forrest A., Bustamante C. I., Standiford H. C. Effect of dose size on bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1987 Jun;31(6):956–958. doi: 10.1128/aac.31.6.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Popper H. H., Winter E., Höfler G. DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol. 1994 Jun;101(6):738–741. doi: 10.1093/ajcp/101.6.738. [DOI] [PubMed] [Google Scholar]
  18. Rajagopalan P., Kumar R., Malaviya A. N. Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever. Clin Exp Immunol. 1982 Feb;47(2):269–274. [PMC free article] [PubMed] [Google Scholar]
  19. Ramachandran S., Godfrey J. J., Perera M. V. Typhoid hepatitis. JAMA. 1974 Oct 14;230(2):236–240. [PubMed] [Google Scholar]
  20. Reichen J. Pharmacologic treatment of cholestasis. Semin Liver Dis. 1993 Aug;13(3):302–315. doi: 10.1055/s-2007-1007358. [DOI] [PubMed] [Google Scholar]
  21. Reid T. M. The treatment of non-typhi salmonellosis. J Antimicrob Chemother. 1992 Jan;29(1):4–8. doi: 10.1093/jac/29.1.4. [DOI] [PubMed] [Google Scholar]
  22. Reisinger E. C., Grasmug E., Krejs G. J. Antibody response after vaccination against typhoid fever in Kurdish refugee camp. Lancet. 1994 Apr 9;343(8902):918–919. doi: 10.1016/s0140-6736(94)90038-8. [DOI] [PubMed] [Google Scholar]
  23. Rocha H., Kirk J. W., Hearey C. D., Jr Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med. 1971 Aug;128(2):254–257. doi: 10.1001/archinte.1971.00310200090009. [DOI] [PubMed] [Google Scholar]
  24. Sulavik S. B., Spencer R. P., Weed D. A., Shapiro H. R., Shiue S. T., Castriotta R. J. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med. 1990 Dec;31(12):1909–1914. [PubMed] [Google Scholar]
  25. Wheat L. J., Rubin R. H., Harris N. L., Smith E. J., Tewari R., Chaudhary S., Lascari A., Mandell W., Garvey G., Goldberg D. Systemic salmonellosis in patients with disseminated histoplasmosis. Case for 'macrophage blockade' caused by Histoplasma capsulatum. Arch Intern Med. 1987 Mar;147(3):561–564. [PubMed] [Google Scholar]
  26. Wolfe M. S., Louria D. B., Armstrong D., Blevins A. Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period. Arch Intern Med. 1971 Oct;128(4):546–554. doi: 10.1001/archinte.128.4.546. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES